These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1602 related items for PubMed ID: 19546558

  • 1. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R, Seidensticker M, Peters N, Mohnike K, Bornschein J, Schütte K, Amthauer H, Malfertheiner P, Pech M, Ricke J.
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [Abstract] [Full Text] [Related]

  • 2. Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction.
    Gaba RC, Riaz A, Lewandowski RJ, Ibrahim SM, Ryu RK, Sato KT, Omary RA, Salem R.
    J Vasc Interv Radiol; 2010 Aug; 21(8):1213-8. PubMed ID: 20598575
    [Abstract] [Full Text] [Related]

  • 3. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK, Omary RA, Gates V, Mounajjed T, Larson AC, Barakat O, Sato KT, Mulcahy M, Gordon S, Lewandowski RJ, Salem R.
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [Abstract] [Full Text] [Related]

  • 4. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
    Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, Atassi B, Baker T, Gates V, Miller FH, Sato KT, Wang E, Gupta R, Benson AB, Newman SB, Omary RA, Abecassis M, Kulik L.
    Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
    [Abstract] [Full Text] [Related]

  • 5. Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center.
    Piana PM, Gonsalves CF, Sato T, Anne PR, McCann JW, Bar Ad V, Eschelman DJ, Parker L, Doyle LA, Brown DB.
    J Vasc Interv Radiol; 2011 Oct; 22(10):1373-9. PubMed ID: 21764600
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
    Rhee TK, Naik NK, Deng J, Atassi B, Mulcahy MF, Kulik LM, Ryu RK, Miller FH, Larson AC, Salem R, Omary RA.
    J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma.
    Hanazaki K, Wakabayashi M, Sodeyama H, Kajikawa S, Amano J.
    Hepatogastroenterology; 1999 Aug; 46(30):3201-7. PubMed ID: 10626186
    [Abstract] [Full Text] [Related]

  • 10. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
    Sangro B, Bilbao JI, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, Panizo A, Gil B, Inarrairaegui M, Herrero I, Quiroga J, Prieto J.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):792-800. PubMed ID: 16904840
    [Abstract] [Full Text] [Related]

  • 11. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
    Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K.
    J Vasc Interv Radiol; 2005 Feb 01; 16(2 Pt 1):195-203. PubMed ID: 15713920
    [Abstract] [Full Text] [Related]

  • 12. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
    Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R, Wust P, Lopez-Hänninen E, Gademann G, Peters N, Berg T, Malfertheiner P, Ricke J.
    Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):172-9. PubMed ID: 20056348
    [Abstract] [Full Text] [Related]

  • 13. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY, Rhee TK, Atassi B, Gates VL, Kulik L, Mulcahy MF, Larson AC, Ryu RK, Sato KT, Lewandowski RJ, Omary RA, Salem R.
    J Vasc Interv Radiol; 2007 Nov 01; 18(11):1375-82. PubMed ID: 18003987
    [Abstract] [Full Text] [Related]

  • 14. The value of liver function tests in hepatocellular carcinoma.
    Lopez JB, Balasegaram M, Thambyrajah V, Timor J.
    Malays J Pathol; 1996 Dec 01; 18(2):95-9. PubMed ID: 10879229
    [Abstract] [Full Text] [Related]

  • 15. Radioembolization in patients with hepatic metastases from breast cancer.
    Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Reiser MF, Helmberger TK.
    J Vasc Interv Radiol; 2008 May 01; 19(5):683-90. PubMed ID: 18440456
    [Abstract] [Full Text] [Related]

  • 16. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
    Chen D, Liang LJ, Peng BG, Zhou Q, Li SQ, Tang D, Huang L, Huang JF.
    Ai Zheng; 2008 Jan 01; 27(1):78-82. PubMed ID: 18184470
    [Abstract] [Full Text] [Related]

  • 17. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
    Kennedy AS, McNeillie P, Dezarn WA, Nutting C, Sangro B, Wertman D, Garafalo M, Liu D, Coldwell D, Savin M, Jakobs T, Rose S, Warner R, Carter D, Sapareto S, Nag S, Gulec S, Calkins A, Gates VL, Salem R.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1494-500. PubMed ID: 19157721
    [Abstract] [Full Text] [Related]

  • 18. Safety of repeated yttrium-90 radioembolization.
    Lam MG, Louie JD, Iagaru AH, Goris ML, Sze DY.
    Cardiovasc Intervent Radiol; 2013 Oct 01; 36(5):1320-8. PubMed ID: 23354961
    [Abstract] [Full Text] [Related]

  • 19. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X, He N, Sun J, Tan J, Zhang C, Yang J, Lu T, Li J.
    Chin Med J (Engl); 1999 May 01; 112(5):430-2. PubMed ID: 11593513
    [Abstract] [Full Text] [Related]

  • 20. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
    Lewandowski RJ, Riaz A, Ryu RK, Mulcahy MF, Sato KT, Kulik LM, Gates VL, Baker T, Omary R, Salem R.
    J Vasc Interv Radiol; 2009 Dec 01; 20(12):1557-63. PubMed ID: 19854068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.